HemoGenyx Pharmaceuticals Plc (5HU0) Financial Statements
HemoGenyx Pharmaceuticals Plc Financial Overview
HemoGenyx Pharmaceuticals Plc's market cap is currently $46.78M. The company's EPS TTM is $-1.81; its P/E ratio is -3.34; HemoGenyx Pharmaceuticals Plc has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ -588.75K | $ -639.28K | $ -645.68K | $ -2.60M | $ -283.65K |
| Operating Income | $ -4.66M | $ -5.73M | $ -5.56M | $ 4.00M | $ -2.70M |
| EBITDA | $ -4.07M | $ -4.71M | $ -5.73M | $ -3.42M | $ -2.39M |
| Net Income | $ -9.76M | $ -5.62M | $ -6.69M | $ -3.98M | $ -5.10M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 1.59M | $ 159.26K | $ 1.25M | $ 2.53M | $ 6.84M |
| Total Assets | $ 4.18M | $ 4.21M | $ 6.11M | $ 7.09M | $ 8.52M |
| Total Debt | $ 2.00M | $ 2.62M | $ 2.95M | $ 3.42M | $ 10.15K |
| Net Debt | $ 417.82K | $ 2.46M | $ 1.70M | $ 890.08K | $ -6.83M |
| Total Liabilities | $ 3.03M | $ 3.36M | $ 3.32M | $ 3.85M | $ 352.84K |
| Stockholders' Equity | $ 1.20M | $ 897.51K | $ 2.82M | $ 3.28M | $ 8.19M |
| Cash Flow | |||||
| Free Cash Flow | $ -3.45M | $ -4.13M | $ -6.22M | $ -3.34M | $ -3.45M |
| Operating Cash Flow | $ -3.45M | $ -4.12M | $ -6.11M | $ -2.91M | $ -2.63M |
| Investing Cash Flow | $ -6.80K | $ -24.90K | $ -31.94K | $ -420.25K | $ -938.95K |
| Financing Cash Flow | $ 4.89M | $ 3.08M | $ 4.45M | $ -110.14K | $ 8.78M |
Currency in GBP
